◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sakar Healthcare Limited (SAKAR) Financial History

Name: Sakar Healthcare Limited (SAKAR) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Sakar Healthcare Limited (SAKAR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 435 employees. Its market capitalization is roughly ₹26 billion. In the fiscal year ended 2026-03-31, SAKAR reported ₹2.5B in revenue and ₹305M in net income.

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India.

Interactive charts & full statements →

SAKAR Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹2.5B	₹1.8B	₹1.5B	₹1.3B	—
Gross Profit	₹1.3B	₹953M	₹697M	₹596M	—
Operating Income (EBIT)	₹467M	₹293M	₹212M	₹191M	—
Net Income	₹305M	₹175M	₹117M	₹128M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SAKAR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹711M	₹703M	₹576M	₹527M	₹502M	—
Gross Profit	₹427M	₹348M	₹272M	₹238M	₹356M	—
Operating Income (EBIT)	₹203M	₹122M	₹57M	₹71M	₹102M	—
Net Income	₹110M	₹102M	₹45M	₹47M	₹58M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SAKAR Free Cash Flow History

SAKAR Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹4.8B	₹4.2B	₹3.9B	₹3.4B	—
Total Liabilities	₹1.6B	₹1.3B	₹1.3B	₹1.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SAKAR viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

2096 · Simcere Pharmaceutical Group Limited — HK$29 billion
HIKAL · Hikal Limited — ₹28 billion
3320 · China Resources Pharmaceutical Group Limited — HK$27 billion
0867 · China Medical System Holdings Limited — HK$27 billion
SHUKRAPHAR · Shukra Pharmaceuticals Limited — ₹25 billion
INDOCO · Indoco Remedies Limited — ₹23 billion
WINDLAS · Windlas Biotech Limited — ₹23 billion
FREDUN · Fredun Pharmaceuticals Limited — ₹22 billion

← SAK All “S” companies SAKHTISUG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.